z-logo
open-access-imgOpen Access
Acute Pancreatitis and Diabetic Ketoacidosis following L-Asparaginase/Prednisone Therapy in Acute Lymphoblastic Leukemia
Author(s) -
Dania Lizet Quintanilla-Flores,
Miguel Ángel Flores-Caballero,
René RodríguezGutiérrez,
Héctor Eloy Tamez-Pérez,
José Gerardo GonzálezGonzález
Publication year - 2014
Publication title -
case reports in oncological medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.173
H-Index - 7
eISSN - 2090-6714
pISSN - 2090-6706
DOI - 10.1155/2014/139169
Subject(s) - medicine , diabetic ketoacidosis , prednisone , pancreatitis , acute pancreatitis , abdominal pain , nausea , vincristine , lymphoblastic lymphoma , gastroenterology , diabetes mellitus , ketonuria , chemotherapy , insulin , endocrinology , cyclophosphamide , immunology , immune system , t cell
Acute pancreatitis and diabetic ketoacidosis are unusual adverse events following chemotherapy based on L-asparaginase and prednisone as support treatment for acute lymphoblastic leukemia. We present the case of a 16-year-old Hispanic male patient, in remission induction therapy for acute lymphoblastic leukemia on treatment with mitoxantrone, vincristine, prednisone, and L-asparaginase. He was hospitalized complaining of abdominal pain, nausea, and vomiting. Hyperglycemia, acidosis, ketonuria, low bicarbonate levels, hyperamylasemia, and hyperlipasemia were documented, and the diagnosis of diabetic ketoacidosis was made. Because of uncertainty of the additional diagnosis of acute pancreatitis as the cause of abdominal pain, a contrast-enhanced computed tomography was performed resulting in a Balthazar C pancreatitis classification.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom